Cover Image

Extramedullary Relapse of Acute Promyelocytic Leukaemia (APL) at an Unusual Site (External Auditory Canal)

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Prathima Iyer, Carole Hudson, Kanwar Sohail, Loredanna Mihailescu, Simon Bolam
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	eJHaem
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Paediatric Acute Myeloid Leukaemia–Myelodysplasia Related With i(17)(q10) Morphologically Mimicking Acute Promyelocytic Leukaemia
by: Kathleen De John, et al.
Published: (2025)

Pleural Infiltration Revealing Post‐Essential Thrombocythemia Acute Myeloid Leukaemia
by: Clémentine Muron, et al.
Published: (2025)

B/T Mixed Phenotype Acute Leukaemia Harbouring NUP98::BPTF Fusion
by: Van Tuong Nguyen, et al.
Published: (2025)

Extramedullary disease in Waldenström macroglobulinemia: A population‐based observational study
by: Simon Østergaard, et al.
Published: (2024)

Phase 2 Multi‐Arm Study of Magrolimab Combinations in Patients With Acute Myeloid Leukaemia
by: Gabriel N. Mannis, et al.
Published: (2025)

Invasive Fungal Disease Associated With Targeted Agents for Acute Myeloid Leukaemia: A Systematic Review
by: Samir Agrawal, et al.
Published: (2025)

Adult Acute Myeloid Leukaemia With DDX3X::MLLT10 : A Rare Entity With Significant Unmet Clinical Needs
by: Jun Yen Ng, et al.
Published: (2025)

Accelerated Chronic Lymphocytic Leukaemia Complicated by Bilateral Pathological Humeral Fractures
by: Mariyum Khawar, et al.
Published: (2026)

Efficacy and Safety of Azacitidine Combined With Lisaftoclax in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome With Increased Blasts
by: Shan Meng, et al.
Published: (2026)

Extramedullary chronic phase chronic myeloid leukaemia (CML) involving the central nervous system: A case report
by: Akshay Deshpande, et al.
Published: (2024)

Durable MRD‐Negative Remission With Blinatumomab and Venetoclax in Heavily Pretreated Relapsed/Refractory Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia
by: Mohammad Shahzaib Qadir, et al.
Published: (2026)

Epcoritamab for Relapsed/Refractory EBV+ Post‐Transplant Lymphoproliferative Disorder of DLBCL‐Type
by: Li Yuan Chan, et al.
Published: (2025)

Uncommon Evolution From Acute Myeloid Leukaemia to JAK2 ‐Mutated Myeloproliferative Neoplasm: Evidence of Clonal Persistence and Divergence From TET2 / SRSF2 ‐Mutated Haematopoietic Progenitors
by: Mark Anthony Turingan, et al.
Published: (2025)

Changes in Common Blood Parameters After Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukaemia
by: Fiona Fernando, et al.
Published: (2025)

Non‐Secretory Myeloma With Non‐Producing Phenotype Presented as Plasma Cell Leukaemia With Plasmablast Morphology
by: Ke Xu, et al.
Published: (2026)

Enhanced Disease Detection of Hairy Cell Leukaemia Through Next‐Generation Sequencing Based BRAFV600E and Phased Variant Analysis
by: Simon Wu, et al.
Published: (2025)

Prescription Behaviour and Drug Interactions of Acid Suppressants With Tyrosine Kinase Inhibitors in Patients With Leukaemia: Data From Germany
by: Marek Lapka, et al.
Published: (2026)

Evidence and Equity Gaps in Clinical Care of Chronic Lymphocytic Leukaemia in Portugal: A Real‐World, Multicentre, Cohort Study
by: Susana Esteves, et al.
Published: (2026)

Allogeneic Hematopoietic Cell Transplantation for Relapsed or Refractory Mantle Cell Lymphoma: Real‐World Outcomes, Late Relapse Patterns, and Clinical Utility in the Chimeric Antigen Receptor T‐Cell Era
by: Enver Aydilek, et al.
Published: (2026)

An Unusual Cause of Hexokinase 1 Deficiency—Case Report
by: Gonench Kilich, et al.
Published: (2025)

Ocular Involvement of Relapsed Nodal T Follicular Helper Cell Lymphoma, Angioimmunoblastic Type
by: Seiya Bamba, et al.
Published: (2026)

Correction to “B‐cell Maturation Antigen‐Based Therapies Post‐Talquetamab in Relapsed or Refractory Multiple Myeloma”
Published: (2025)

Dynamic Profiling of Cell Free Tumour DNA in Aggressive B‐Cell Lymphoma From Diagnosis to Transformation at Relapse
by: Mark Waltham, et al.
Published: (2025)

T‐Cell Receptor Repertoires Show Dynamic Variation Between Diagnosis and Relapse of Diffuse Large B‐Cell Lymphoma
by: Joel Wight, et al.
Published: (2025)

Alternative 5‐Azacitidine 5‐Day 100 mg/m 2 Dosage Shows Non‐Inferiority to Classical Schedule for Myelodysplastic Neoplasm (MDS) and Chronic Myelomonocytic Leukaemia (CMML) Treatment
by: Gerasimos Tsilimidos, et al.
Published: (2025)

Final Results of a Phase 2 Multi‐Arm Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma
by: Barry Paul, et al.
Published: (2025)

Donor‐Derived T‐Cell Redirection With Epcoritamab Achieving Complete Response After Early Post‐Allo‐HSCT Relapse of DLBCL
by: Yoshikazu Ikoma, et al.
Published: (2025)

A Real‐World Study of Tafasitamab for the Treatment of Relapsed or Refractory Diffuse Large B‐Cell Lymphoma in the United States
by: Kim Saverno, et al.
Published: (2026)

An Unusual Case of Severe Vitamin B12 Deficiency With Early Erythroblasts on Peripheral Blood Film
by: Jessica Muscat, et al.
Published: (2025)

Early Free Light‐Chain Suppression as a Prognostic Marker in Relapsed and Refractory Myeloma Patients Treated With BCMA‐Directed CAR‐T Cells
by: Tim Richardson, et al.
Published: (2025)

Machine Learning Algorithm to Explore Patients With Heterogeneous Treatment Effects of Clinically Significant CMV Infection and Non‐Relapse Mortality After HSCT
by: Takashi Toya, et al.
Published: (2025)

What Is Acute Myeloid Leukemia?
by: Daniel Mazza Matos, et al.
Published: (2025)

Relapsed Philadelphia chromosome‐positive B‐cell acute lymphoblastic leukaemia responds well to a combination of modified hyper‐CVAD, blinatumomab and tyrosine kinase inhibitor
by: Gaétan Basile, et al.
Published: (2025)

Nivolumab Induces Durable Remission in Relapsed/Refractory ALK‐Negative ALCL After Allogeneic Blood Stem Cell Transplantation—A Case Report and Literature Review
by: Ben‐Niklas Baermann, et al.
Published: (2025)

Assessment of the Tolerability and Optimal Dosing of the Combination of Brentuximab Vedotin and Lenalidomide in Patients With Relapsed or Refractory T‐cell Lymphoma: Results of a Single‐centre Phase 1 Dose‐escalation Study
by: Carrie van der Weyden, et al.
Published: (2025)

Adipocytes Impair Mitoxantrone Cytotoxicity Against Acute Lymphoblastic Leukemia
by: Michael Cohen, et al.
Published: (2025)

Rapid Identification of DUX4::IGH Fusion in Acute Lymphoblastic Leukemia
by: Kyoko Moritani, et al.
Published: (2025)

Outcomes With Venetoclax 50 mg, Hypomethylating Agents, and Voriconazole or Posaconazole in Acute Myeloid Leukemia
by: Kendall Diebold, et al.
Published: (2025)

A Unique Case of Concomitant T‐Prolymphocytic Leukemia and B‐Cell Acute Lymphoblastic Leukemia
by: Viral M. Patel, et al.
Published: (2026)

Standardization of Measurable Residual Disease in Acute Myeloid Leukemia by Flow Cytometry: A Multicenter Study
by: Maura Rosane Valerio Ikoma‐Colturato, et al.
Published: (2025)